Scientific Advisory Board

Dr. Voros is Chief Scientific Officer, Chief of the Center of Wellness for Prevention and Women's Heart Disease, and Medical Director of the Cardiovascular Magnetic Resonance Imaging and Computed Tomography Division at the Piedmont Heart Institute (PHI) in Atlanta, GA. He oversees all research operations at PHI, which has over 70 clinical research studies ongoing. In addition, Dr. Voros heads up the comprehensive cardiovascular prevention program at the Piedmont Heart Institute, bringing an integrated approach to heart disease by incorporating genetic and genomic medicine, advanced metabolic evaluation and non-invasive imaging into everyday patient care. As Medical Director for Cardiovascular Magnetic Resonance Imaging and Computed Tomography at PHI, he oversees one of the most active clinical and research imaging programs in the country. Dr. Voros conducts an active research program in imaging of atherosclerosis using various modalities and investigating the effect of lipid-modifying therapies on atherosclerosis using novel imaging approaches. He is a Principal Investigator on numerous local and national clinical studies in the field of genetics, genomics and advanced imaging. He has 25 recent publications in his fields of interest. As Chairman of HemoShear's Scientific Advisory Board, Dr. Voros was instrumental in helping select compounds for HemoShear's proof of concept program to validate the technology with known human drug successes and failures. Dr. Voros received his medical training at the University Medical School of Pecs in Hungary, was Chief Medical Resident at the University of Alabama at Birmingham, and was Chief Cardiovascular Fellow in the Cardiovascular Division at the University of Virginia Medical Center.

Dr. Beller is the Ruth C. Heede Professor of Cardiology and former Chief of the Cardiovascular Division at the University of Virginia Health System. Dr. Beller's research has predominantly been in the field of nuclear cardiology, with emphasis on developing non-invasive techniques for detection of coronary artery disease, assessing prognosis and myocardial viability. He has more than 425 publications, is the author of Clinical Nuclear Cardiology (published by W.B. Saunders), and co-edited Nuclear Cardiology: State of the Art and Future Directions, the 4th edition of which will be published in 2009. He is currently Editor-in-Chief of the Journal of Nuclear Cardiology. Dr. Beller has played a national leadership role in a number of cardiovascular organizations. He was Chairman of the Council on Clinical Cardiology of the American Heart Association (AHA) and Chair of the AHA Scientific Advisory Committee. He served 12 years on the American College of Cardiology (ACC) Board of Trustees, was Chairman of the ACC Board of Governors, and then President of the College (2000-2001). In 1995, he was President of the Association of Professors of Cardiology and, in 1999, served as President of the Association of University Cardiologists. He is the recipient of the Distinguished Achievement Award and the James B. Herrick Award from the American Heart Association, the Walter Reed Distinguished Achievement Award from the University of Virginia and the Lifetime Achievement Award from the Paul Dudley White Society of Massachusetts General Hospital. Dr. Beller received his undergraduate degree from Dartmouth College (1962) and his M.D. from the University of Virginia (1966), after which he undertook internal medicine residency training at the University of Wisconsin Hospitals and the Boston City Hospital. After spending three years on the staff of Massachusetts General Hospital, he returned to UVa in 1977 as Chief of the Cardiovascular Division. He served in that position for 28 years. He was the President of the Clinical Staff at UVa from 1998 to 2004.

Dr. Pruett is the John S. Najarian Clinical Chair of Transplantation Surgery at the University of Minnesota School of Medicine. The former Charles O. Strickler Professor of Surgery and Chief of Transplantation at the University of Virginia Medical Center, Dr. Pruett is certified by the American Boards of Internal Medicine and Surgery and has subspecialty certificates in Infectious Diseases and Critical Care, in addition to having completed a transplantation fellowship. His research interests have focused primarily on infections in transplant recipients and, in particular, the interactions of the viral hepatides and the transplanted liver. He has over 200 publications, most on transplant-related issues and infections, and has a longstanding interest in access of care in international health, particularly with programs in Saudi Arabia and Vietnam. Dr. Pruett is a national leader in raising awareness of organ donation, addressing ethics questions, and maximizing yield and safety of donated organs. He recently completed the leadership cycle for the United Network for Organ Sharing (UNOS), including serving as President. He is a council member of the American Society of Transplant Surgeons and serves on the Transplantation Advisory Committee of the American Board of Surgery and the Board of Directors of LifeNet Health. Dr. Pruett received his B.S. in Chemistry and Philosophy from Wheaton College (1973) and his M.D. from the Baylor College of Medicine (1976), after which he undertook internal medicine training at the University of Michigan and surgical residency and transplant training at the University of Minnesota.